Literature DB >> 35702109

Total intravenous anesthesia without muscle relaxant for pulmonary wedge resection in a patient with amyotrophic lateral sclerosis: a case report.

Hyeon Tae Kim1, Jin Ho Bae1, Young Duck Shin1, Jin Sol Lee1, Yea Ji Kim1, Joo Yong Lee1.   

Abstract

Muscle relaxants may exacerbate the symptoms of amyotrophic lateral sclerosis (ALS). Furthermore, ALS patients often experience respiratory muscle weakness. Herein, we report the case of a 63-year-old man with ALS who underwent pulmonary wedge resection using total intravenous anesthesia without muscle relaxant and single lumen endotracheal tube. After an unremarkable surgical procedure, the patient was transferred to the intensive care unit after extubation. The patient did not experience any worsening of ALS symptoms over the one-year follow-up period. Our experience shows that total intravenous anesthesia without muscle relaxants can be used as an anesthetic method for lung surgery in ALS patients. We report this case along with a brief literature review. AJTR
Copyright © 2022.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; general anesthesia; neurodegenerative diseases; neuromuscular blocking agents; video assisted thoracic surgery

Year:  2022        PMID: 35702109      PMCID: PMC9185035     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   3.940


  14 in total

1.  A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host.

Authors:  Anton Bom; Mark Bradley; Ken Cameron; John K Clark; Jan Van Egmond; Helen Feilden; Elizabeth J MacLean; Alan W Muir; Ronald Palin; David C Rees; Ming-Qiang Zhang
Journal:  Angew Chem Int Ed Engl       Date:  2002-01-18       Impact factor: 15.336

2.  Patients who survive 5 years or more with ALS in Olmsted County, 1925-2004.

Authors:  Farrah J Mateen; Marco Carone; Eric J Sorenson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-07-13       Impact factor: 10.154

3.  Epidural anesthesia and pulmonary function in a patient with amyotrophic lateral sclerosis.

Authors:  K Hara; S Sakura; Y Saito; M Maeda; Y Kosaka
Journal:  Anesth Analg       Date:  1996-10       Impact factor: 5.108

4.  Total intravenous anesthesia without muscle relaxant in a parturient with amyotrophic lateral sclerosis undergoing cesarean section: A case report.

Authors:  Wei Xiao; Lei Zhao; Fengying Wang; Hong Sun; Tianlong Wang; Guoguang Zhao
Journal:  J Clin Anesth       Date:  2016-12-01       Impact factor: 9.452

Review 5.  Amyotrophic Lateral Sclerosis.

Authors:  Robert H Brown; Ammar Al-Chalabi
Journal:  N Engl J Med       Date:  2017-07-13       Impact factor: 91.245

Review 6.  Amyotrophic lateral sclerosis and anesthesia: a case series and review of the literature.

Authors:  Alan M Hoeper; David W Barbara; James C Watson; Juraj Sprung; Toby N Weingarten
Journal:  J Anesth       Date:  2019-01-17       Impact factor: 2.078

7.  Spinal Anesthesia for Amyotrophic Lateral Sclerosis Patient Undergoing Lower Extremity Orthopedic Surgery: An Overview of the Anesthetic Considerations.

Authors:  Jason K Panchamia; Carmelina Gurrieri; Adam W Amundson
Journal:  Int Med Case Rep J       Date:  2020-07-07

Review 8.  Anaesthetic considerations for patients with a pre-existing neurological deficit: are neuraxial techniques safe?

Authors:  M Vercauteren; L Heytens
Journal:  Acta Anaesthesiol Scand       Date:  2007-05-04       Impact factor: 2.105

9.  Effects of Propofol on Respiratory Drive and Patient-ventilator Synchrony during Pressure Support Ventilation in Postoperative Patients: A Prospective Study.

Authors:  Ling Liu; Ai-Ping Wu; Yi Yang; Song-Qiao Liu; Ying-Zi Huang; Jian-Feng Xie; Chun Pan; Cong-Shan Yang; Hai-Bo Qiu
Journal:  Chin Med J (Engl)       Date:  2017-05-20       Impact factor: 2.628

10.  Incomplete recovery from rocuronium-induced muscle relaxation in patients with amyotrophic lateral sclerosis using sugammadex: A case report.

Authors:  Hea Rim Chun; Jinhun Chung; Nan Seol Kim; A Joo Kim; Suro Kim; Kyu Sik Kang
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.